US 11,795,178 B2
Compositions of thienopyrimidine derivatives
Koichiro Fukuoka, Osaka (JP); Kazuhiro Miwa, Osaka (JP); Tsuyoshi Sasaki, Osaka (JP); and Fumiya Komura, Osaka (JP)
Assigned to Takeda Pharmaceutical Company Limited, Osaka (JP)
Filed by Takeda Pharmaceutical Company Limited, Osaka (JP)
Filed on Mar. 14, 2022, as Appl. No. 17/694,635.
Application 16/116,804 is a division of application No. 15/481,505, filed on Apr. 7, 2017, granted, now 10,150,778, issued on Dec. 11, 2018.
Application 15/481,505 is a division of application No. 14/432,188, granted, now 9,758,528, issued on Sep. 12, 2017, previously published as PCT/JP2013/077013, filed on Sep. 27, 2013.
Application 17/694,635 is a continuation of application No. 17/349,584, filed on Jun. 16, 2021.
Application 17/349,584 is a continuation of application No. 16/710,390, filed on Dec. 11, 2019, granted, now 11,053,257, issued on Jul. 6, 2021.
Application 16/710,390 is a continuation of application No. 16/116,804, filed on Aug. 29, 2018, granted, now 10,544,160, issued on Jan. 28, 2020.
Claims priority of application No. 2012/217679 (JP), filed on Sep. 28, 2012.
Prior Publication US 2022/0204525 A1, Jun. 30, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 495/04 (2006.01); C07D 333/38 (2006.01); C07D 409/12 (2006.01)
CPC C07D 495/04 (2013.01) [C07D 333/38 (2013.01); C07D 409/12 (2013.01)] 87 Claims
 
1. A mixture comprising 1-{441-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea, or a salt or solvate thereof, and 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione.